Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: September 5, 2005
Last updated: November 18, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)